ticarcillin-clavulanic acid. The isolates were susceptible to polymyxin B and aztreonam, and had intermediate resistance to amikacin.
Multiresistant P. aeruginosa is a therapeutic challenge when managing patients with such infections. 3 In the context of facilities such as large burns units or intensive care units, the presence of plasmid-transmissible carbapenem resistance within the gram-negative bacterial population has serious infection control implications. Until novel molecular real-time PCR methods became available, the underlying mechanism of carbapenem resistance in these organisms could not be adequately delineated. The increasing availability of such molecular technology and its routine application in the diagnostic laboratory will support appropriate antibiotic prescribing practices and enhance infection control measures in the hospital setting.
Identification of a plasmid-mediated carbapenem-resistant strain is a concern in our hospital and throughout Australia, as outbreaks of VIM-1 resistance have been reported in Europe and the United States. 4 As demonstrated by our isolates, such strains have a broad spectrum of hydrolytic activity against amino-, carboxyl-and u re id o-pe nic il lins , c e pha lo s po rins , cephamycins and carbapenems, but not monobactams. Our isolate was susceptible only to polymyxin and aztreonam. 
